tirzepatide or mounjaro which is better (Mounjaro & Zepbound) for Weight Loss in Singapore The Weight Loss Showdown: Mounjaro

Common side effects include nausea, vomiting, diarrhea, constipation, headaches and injection site reactions (redness, swelling, irritation)

Stomach and abdominal pain Stomach and abdominal pain, including upper and lower, is reported in about 20% of people taking Wegovy in clinical trials, with similar rates expected for the oral tablet

Wegovy Coverage with the New Cardiovascular Indication On March 8, 2024, the Food and Drug Administration (FDA) approved a new indication for the use of Wegovy (semaglutide) injections to reduce the risk of cardiovascular death, heart attack, and stroke in adults who have cardiovascular disease and are either obese or overweight

Contact CyberSquad IT Consulting for more information.

We watch platelet counts closely to keep mom and baby safe